Literature DB >> 106878

Nuclear protein modification and chromatin substructure. 3. Relationship between poly(adenosine diphosphate) ribosylation and different functional forms of chromatin.

D B Jump, T R Butt, M Smulson.   

Abstract

The relationship between poly(adenosine diphosphate) ribosylation of nuclear proteins and functionally different forms of chromatin from mid-S-phase HeLa nuclei was investigated. The major observations emerging from this study were that unique nonhistone proteins were modified in mid-S-phase HeLa nuclei. The major acceptor for poly(adenosine diphosphate-ribose) [poly(ADP-Rib)] was an internucleosomal nonhistone protein (protein C; 125 000 molecular weight). Histones H3, H1, H2b, and H2a but not H4 were ADP-ribosylated in S-phase nuclei. Chromatin fragments preferentially released by micrococcal nuclease were enriched in nonhistone proteins, poly(ADP)-ribosylated nuclear proteins, poly(ADP-Rib) polymerase activity and nascent DNA from the DNA replicating fork. In extended forms of chromatin, contiguous to the DNA replicating fork, poly(ADP-Rib) polymerase was maximally active. However, in chromatin distal to the replicating fork (i.e., more condensed structures), nucleosomal histones and histone H1 were not significantly ADP-ribosylated, and poly(ADP-Rib) polymerase activity was depressed two- to threefold. The data suggest that a subset of nucleosomes in extended regions of chromatin is subject to extensive ADP ribosylation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 106878     DOI: 10.1021/bi00573a008

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

Review 1.  Exploring the emerging complexity in transcriptional regulation of energy homeostasis.

Authors:  Adelheid Lempradl; J Andrew Pospisilik; Josef M Penninger
Journal:  Nat Rev Genet       Date:  2015-10-13       Impact factor: 53.242

2.  Functional Interplay between Histone H2B ADP-Ribosylation and Phosphorylation Controls Adipogenesis.

Authors:  Dan Huang; Cristel V Camacho; Rohit Setlem; Keun Woo Ryu; Balaji Parameswaran; Rana K Gupta; W Lee Kraus
Journal:  Mol Cell       Date:  2020-08-20       Impact factor: 17.970

3.  Antibody to poly(adenosine diphosphate-ribose) polymerase and its use in chromatin analysis.

Authors:  N Malik; M Bustin; M Smulson
Journal:  Nucleic Acids Res       Date:  1982-05-11       Impact factor: 16.971

Review 4.  Introductory review: involvement of ADP-ribosylation in cellular recovery from some forms of DNA damage.

Authors:  J Lunec
Journal:  Br J Cancer Suppl       Date:  1984

5.  Immunological evidence for the in vivo occurrence of a crosslinked complex of poly(ADP-ribosylated) histone H1.

Authors:  M Wong; Y Kanai; M Miwa; M Bustin; M Smulson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

6.  Cloning and expression of cDNA for human poly(ADP-ribose) polymerase.

Authors:  H M Alkhatib; D F Chen; B Cherney; K Bhatia; V Notario; C Giri; G Stein; E Slattery; R G Roeder; M E Smulson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

7.  TFIIF, a basal eukaryotic transcription factor, is a substrate for poly(ADP-ribosyl)ation.

Authors:  J M Rawling; R Alvarez-Gonzalez
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

8.  Immunoaffinity fractionation of the poly(ADP-ribosyl)ated domains of chromatin.

Authors:  N Malik; M Miwa; T Sugimura; P Thraves; M Smulson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

9.  The production of antibodies to DNA in normal mice following immunization with poly(ADP-ribose).

Authors:  J T Sibley; R P Braun; J S Lee
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

10.  PARP is activated at stalled forks to mediate Mre11-dependent replication restart and recombination.

Authors:  Helen E Bryant; Eva Petermann; Niklas Schultz; Ann-Sofie Jemth; Olga Loseva; Natalia Issaeva; Fredrik Johansson; Serena Fernandez; Peter McGlynn; Thomas Helleday
Journal:  EMBO J       Date:  2009-07-23       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.